CD80 and rheumatoid arthritis: Many clinical trials also show the bone-protective effect of abatacept in RA, suggesting that in inflammatory bone-resorptive disorders, B7 molecules represent a novel therapeutic avenue for the development of anti-osteoclastogenic therapy.